• OPEN AN ACCOUNT
Indian Indices
Nifty
23,190.65 283.05
(1.24%)
Sensex
76,348.06 899.01
( 1.19%)
Bank Nifty
50,062.85 360.25
( 0.72%)
Nifty IT
36,676.65 453.15
( 1.25%)
Global Indices
Nasdaq
41,985.63 383.32
(0.92%)
Dow Jones
5,690.25 -0.25
(0.00%)
Hang Seng
37,858.63 13.21
(0.03%)
Nikkei 225
8,718.48 13.25
(0.15%)
Forex
USD-INR
86.61 -0.19
(-0.22%)
EUR-INR
94.64 0.03
(0.03%)
GBP-INR
112.48 -0.04
(-0.04%)
JPY-INR
0.58 0.00
(-0.67%)

EQUITY - MARKET SCREENER

JFL Life Sciences Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
535469
INE0LA901015
10.7819648
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
JFLLIFE
18.75
61.87
EPS(TTM)
Face Value()
Div & Yield %
1
10
0.44
 

state bank of india
Bajaj Auto total sales gains 7% YoY in January
Feb 03,2025

While the company’s domestic sales decreased 9% to 2,08,359 units, exports jumped by 31% to 1,72,681 units in January 2025 over January 2024.

Sales of two-wheelers stood at 1,71,299 units (down 11% YoY) and commercial vehicles was 37,060 units (up 1% YoY).

Bajaj Auto is engaged in the business of development, manufacturing, and distribution of automobiles such as motorcycles, commercial vehicles, electric two-wheelers, etc. and parts thereof.

The auto major’s standalone net profit increased 9.19% to Rs 2,005.04 crore on a 21.80% jump in revenue from operations to Rs 13,127.47 crore in Q2 FY25 over Q2 FY24.

Shares of Bajaj Auto fell 1.14% to Rs 9,044.15 on the BSE.